Pasi Halonen

Pasi Halonen

UNVERIFIED PROFILE

Are you Pasi Halonen?   Register this Author

Register author
Pasi Halonen

Pasi Halonen

Publications by authors named "Pasi Halonen"

Are you Pasi Halonen?   Register this Author

14Publications

386Reads

30Profile Views

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity.

Oncotarget 2017 Sep 19;8(43):73925-73937. Epub 2017 May 19.

Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650312PMC
September 2017

A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.

Eur Urol 2017 06 17;71(6):858-862. Epub 2017 Jan 17.

Division of Molecular Carcinogenesis, Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.01.021DOI Listing
June 2017

Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na.

Mol Cancer Ther 2014 May 18;13(5):1054-66. Epub 2014 Apr 18.

Authors' Affiliations: VTT Health, VTT Technical Research Centre of Finland; Centre for Biotechnology and Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku; Drug Research Doctoral Programme and FinPharma Doctoral Program Drug Discovery; School of Pharmacy, University of Eastern Finland, Kuopio, Finland; and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0685DOI Listing
May 2014

Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase.

BMC Cancer 2010 Jan 7;10. Epub 2010 Jan 7.

VTT Technical Research Centre of Finland, Medical Biotechnology, Itainen Pitkakatu 4B, FIN-20520 Turku, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820462PMC
January 2010

Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer.

Int J Cancer 2008 Dec;123(12):2774-81

Medical Biotechnology, VTT Technical Research Centre of Finland, Institute for Molecular Medicine Finland and University of Turku, Turku, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.23885DOI Listing
December 2008

Single-turnover kinetics of Saccharomyces cerevisiae inorganic pyrophosphatase.

Biochemistry 2002 Oct;41(40):12025-31

Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi026018zDOI Listing
October 2002